Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;8(12):1051-1061.
doi: 10.4155/tde-2017-0093.

Pulmonary aerosol delivery and the importance of growth dynamics

Allen E Haddrell  1 , David Lewis  2 , Tanya Church  2 , Reinhard Vehring  3 , Darragh Murnane  4 , Jonathan P Reid  1
Affiliations

Pulmonary aerosol delivery and the importance of growth dynamics

Allen E Haddrell et al. Ther Deliv. 2017 Dec.

Abstract

Aerosols are dynamic systems, responding to variations in the surrounding environmental conditions by changing in size, composition and phase. Although, widely used in inhalation therapies, details of the processes occurring on aerosol generation and during inhalation have received little attention. Instead, research has focused on improvements to the formulation of the drug prior to aerosolization and the resulting clinical efficacy of the treatment. Here, we highlight the processes that occur during aerosol generation and inhalation, affecting aerosol disposition when deposited and, potentially, impacting total and regional doses. In particular, we examine the response of aerosol particles to the humid environment of the respiratory tract, considering both the capacity of particles to grow by absorbing moisture and the timescale for condensation to occur. [Formula: see text].

Keywords: aerosol microphysics; condensation; drug delivery to the lungs; inhalation; moisture.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

JP Reid and AE Haddrell acknowledge financial support from Chiesi Ltd who contributed partial funding for this work. JP Reid acknowledges financial support from the EPSRC through grant EP/N025245/1. D Lewis and T Church are employees of Chiesi Ltd, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. Aerosols can be formulated for a number of delivery modalities including metered dose inhalers and dry powder inhalers, producing solutions, suspensions or dry powders.
The outcome of the therapy can be dependent on the formulation. Aerosolization and aerosol processing are key intermediate steps that are often ignored when considering the delivery of drugs to the lungs but result in rapid changes in particle size, phase, morphology and composition, thereby affecting deposition pattern, disposition and, possibly, clinical efficacy.
<b>Figure 2.</b>
Figure 2.. Particles respond to changes in the surrounding relative humidity of the gas phase by absorbing water and growing in size.
Here, the growth in size is represented as a diameter growth factor which reports the change in particle size relative to the dry particle as the relative humidity increases. Growth curves for particles of increasing hygroscopicity parameter (= 0.01, 0.12 and 1.27) are shown as examples of insoluble, low solubility and high solubility, respectively.
<b>Figure 3.</b>
Figure 3.. Simulations of the response in size of sodium chloride droplets to a step change in the relative humidity surrounding for aerosol particles of varying initial size (note the log diameter axis).
<b>Figure 4.</b>
Figure 4.. Dynamic behavior of pharmaceutical aerosol prior to, and during, inhalation.
(A) A simulation of the time-dependence of the size of particles of varying composition during condensation following a step change in relative humidity. (B) A comparison of the kinetics of particle size change during initial equilibration of an aqueous sodium chloride solution droplet following injection into a gas phase of lower RH than the starting water activity in the droplet, followed by condensation of water once the relative humidity is increased. The measurements were made with an EDB detailed in our previous work [10,34]. The model parameterization includes a quasi-steady analytical treatment of the coupling of heat and mass transport during water evaporation or condensation [34,39,41]. EDB: Electrodynamic balance; RH: Relative humidity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 2003;56(6):600–612. http://doi.wiley.com/10.1046/j.1365–2125.2003.01893.x - DOI - PMC - PubMed
    1. Forbes B, Asgharian B, Dailey LA, et al. Challenges in inhaled product development and opportunities for open innovation. Adv. Drug Deliv. Rev. 2010;63(1–2):69–87. www.ncbi.nlm.nih.gov/pubmed/21144875 - PubMed
    1. Ulrik CS, Lange P. Targeting small airways in asthma: improvement in clinical benefit? Clin. Respir. J. 2011;5(3):125–30. www.ncbi.nlm.nih.gov/pubmed/21106032 - PubMed
    1. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 2003;56(6):588–599. - PMC - PubMed
    1. Smyth HDC. Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 2005;2(1):53–74. - PubMed

LinkOut - more resources